Timothy Smith
Internal Medicine · Saint Peters, MONPI 1275502049
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $288,393 of the $427,764 with a category attached, or 67.4%. 20 manufacturers reported payments, led by Lilly USA, LLC at 54.5% of the total. Reporting peaked in 2019 at $143,464 and has fallen 99.3% since, to $1,036 in 2025. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 700 payments — averaging $611.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$233K
- Amgen$70K
- Eli Lilly$48K
- AbbVie$31K
- Biohaven Pharmaceuticals, Inc.$16K
- Biohaven Pharmaceutical Holding Company Ltd.$8K
- plus $22K from 14 others
Across 1,730 payments — averaging $12,258 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$15.7M
- Pfizer$1.7M
- Boehringer Ingelheim$638K
- AbbVie$615K
- Novo Nordisk AS$546K
- Novartis$386K
- plus $1.6M from 14 others
What the payments were for
- Consulting fees$81,82019%
- Speaking & faculty fees$288,39367%
- Grants$440%
- Travel & lodging$46,61211%
- Food & beverage$10,6932%
- Education$2030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 329 | $233,029 |
| Amgen | 74 | $69,588 |
| Eli Lilly | 151 | $48,463 |
| AbbVie(2 entities) | 43 | $31,027 |
| Biohaven Pharmaceuticals, Inc. | 28 | $16,376 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $7,562 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $6,902 |
| Teva Pharmaceuticals USA, Inc. | 7 | $5,374 |
| Pfizer | 9 | $5,012 |
| Boehringer Ingelheim International GmbH | 13 | $1,653 |
| Alnylam Pharmaceuticals Inc. | 8 | $1,053 |
| Lundbeck LLC | 8 | $636 |
| Novartis | 5 | $574 |
| Promius Pharma LLC | 4 | $183 |
| Boston Scientific | 2 | $131 |
| Tonix Medicines, Inc. | 2 | $114 |
| Boehringer Ingelheim | 1 | $48 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Verona Pharma, Inc. | 1 | $14 |
| Inogen, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$427,764 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Saint Peters
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
- Justin SteinkampSaint Charles$139K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- William SummersSaint Louis$93K
- Mark ScheperleSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.